Study of a stent for narrowed lung blood vessels
Part of Heart & circulation clinical trials.
This study looks at a stent called PALMAZ MULLINS XD that is placed in the lung's blood vessels to help keep them open. It aims to see how well the stent works in real-world use for people with pulmonary artery stenosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are treated with the PALMAZ MULLINS XD pulmonary stent.
- Your doctor decides the stent is appropriate based on the stent's instructions for use.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks the safety of the Minima Stent System over time. It is for people who need a stent to keep their blood vessel open. The study wants to see how the device works in real-world use.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
This trial tests a special way of inflating a balloon after placing a stent in a blocked heart artery. It aims to improve how well the stent expands, which may help keep the artery open.
This trial tests a special balloon to treat narrowed areas inside a previously placed heart stent. It may help by reopening the artery without adding another stent.
This trial tests whether a special drug-coated balloon (“MagicTouch”) can treat re-narrowing inside a previously placed stent. It may help patients whose stent has become blocked again, by improving blood flow and reducing repeat narrowing.
This study tests a procedure to widen a narrowed airway (not caused by cancer) using a silicone stent placed during a tube-based procedure called bronchoscopy. The goal is to see if this helps you breathe better and prevents infections behind the narrowing.
Hear when a new Pulmonary Artery Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.